Assembly Biosciences ASMB EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Assembly Biosciences’s reported figures.
Based on trailing twelve months.
The official record: Assembly Biosciences’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Assembly Biosciences's EBITDA margin?
- Assembly Biosciences (ASMB) reported EBITDA margin of -116.5% in Q3 2025.
- How has Assembly Biosciences's EBITDA margin changed year-over-year?
- Assembly Biosciences's EBITDA margin increased by 28.7% year-over-year, from -163.3% to -116.5%.
- What is the long-term trend for Assembly Biosciences's EBITDA margin?
- Over 2 years (2020 to 2024), Assembly Biosciences's EBITDA margin has grown at a 40.0% compound annual growth rate (CAGR), from -81% to -158.8%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.